デフォルト表紙
市場調査レポート
商品コード
1085481

SNPジェノタイピング・分析の世界市場:技術別、アプリケーション別、地域別-規模、シェア、展望、機会分析(2022年~2028年)

SNP Genotyping and Analysis Market, By Technology, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 181 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
SNPジェノタイピング・分析の世界市場:技術別、アプリケーション別、地域別-規模、シェア、展望、機会分析(2022年~2028年)
出版日: 2022年05月17日
発行: Coherent Market Insights
ページ情報: 英文 181 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

予測期間中のSNPジェノタイピング・分析市場の成長を妨げる主な要因として、大量の冗長データをもたらす不完全なプロトコル、デバイスの高コストが考えられます。

当レポートでは、世界のSNPジェノタイピング・分析市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査目的・前提条件

  • 調査目的
  • 仮定
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場の内訳:技術別
    • 市場の内訳:アプリケーション別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、および動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • PEST分析
  • COVID-19影響分析

第4章 世界のSNPジェノタイピング・分析市場:技術別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • SNPマイクロアレイ
  • TaqMan直接配列決定
  • SNPパイロシーケンス技術
  • ABISNPlex
  • Sequenom Mass-Array MALDI-TOF
  • その他

第5章 世界のSNPジェノタイピング・分析市場:アプリケーション別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 医薬品・薬理ゲノミクス
  • 診断調査
  • 農業・バイオテクノロジー
  • 育種・家畜

第6章 世界のSNPジェノタイピング・分析市場:地域別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 北米
  • 米国
  • カナダ
  • 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • ASEAN
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
  • 中東
  • GCC諸国
  • イスラエル
  • その他中東
  • アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第7章 競合情勢

  • 企業プロファイル
    • LGC Limited
    • Fluidigm Corporation
    • Illumina, Inc.
    • Life Technologies Corporation
    • PREMIER Biosoft
    • Thermo Fisher Scientific
    • Sequenom, Inc.

第8章 セクション

  • 参考文献
  • 調査手法
  • 当社と営業担当者について
目次
Product Code: CMI3972

Genotyping refers to determining differences in the genetic make-up by analyzing DNA sequences of individuals. Genotyping has wide variety of applications ranging from drug discovery to disease diagnosis. Genetic diseases (which have different genetic make ups in certain places in DNA) can be identified and diagnosed by comparing those sequences with the reference sequences.

Restraints of the Global SNP Genotyping and Analysis Market

Major factors hampering the growth of the SNP genotyping and analysis market during the forecast period constitutes of imperfect protocols leading to large redundant data, and high costs of devices.

Key features of the study:

  • This report provides in-depth analysis of the global SNP genotyping and analysis market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global SNP genotyping and analysis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include LGC Limited, Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, and Sequenom, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global SNP genotyping and analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global SNP Genotyping and Analysis Market, By Technology:
    • SNP Microarray
    • Taqman Allelic Discrimination
    • SNP Pyrosequencing Technologies
    • ABISNPlex
    • Sequenom Mass-Array MALDI-TOF
    • Others
  • Global SNP Genotyping and Analysis Market, By Application:
    • Pharmaceuticals and Pharmacogenomics
    • Diagnostic Research
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
  • Global SNP Genotyping and Analysis Market, By Geography:
    • North America
  • By Technology
    • SNP Microarray
    • Taqman Allelic Discrimination
    • SNP Pyrosequencing Technologies
    • ABISNPlex
    • Sequenom Mass-Array MALDI-TOF
    • Others
  • By Application
    • Pharmaceuticals and Pharmacogenomics
    • Diagnostic Research
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Technology
    • SNP Microarray
    • Taqman Allelic Discrimination
    • SNP Pyrosequencing Technologies
    • ABISNPlex
    • Sequenom Mass-Array MALDI-TOF
    • Others
  • By Application
    • Pharmaceuticals and Pharmacogenomics
    • Diagnostic Research
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Technology
    • SNP Microarray
    • Taqman Allelic Discrimination
    • SNP Pyrosequencing Technologies
    • ABISNPlex
    • Sequenom Mass-Array MALDI-TOF
    • Others
  • By Application
    • Pharmaceuticals and Pharmacogenomics
    • Diagnostic Research
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Technology
    • SNP Microarray
    • Taqman Allelic Discrimination
    • SNP Pyrosequencing Technologies
    • ABISNPlex
    • Sequenom Mass-Array MALDI-TOF
    • Others
  • By Application
    • Pharmaceuticals and Pharmacogenomics
    • Diagnostic Research
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Technology
    • SNP Microarray
    • Taqman Allelic Discrimination
    • SNP Pyrosequencing Technologies
    • ABISNPlex
    • Sequenom Mass-Array MALDI-TOF
    • Others
  • By Application
    • Pharmaceuticals and Pharmacogenomics
    • Diagnostic Research
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Technology
    • SNP Microarray
    • Taqman Allelic Discrimination
    • SNP Pyrosequencing Technologies
    • ABISNPlex
    • Sequenom Mass-Array MALDI-TOF
    • Others
  • By Application
    • Pharmaceuticals and Pharmacogenomics
    • Diagnostic Research
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • LGC Limited *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Fluidigm Corporation
    • Illumina, Inc.
    • Life Technologies Corporation
    • PREMIER Biosoft
    • Thermo Fisher Scientific
    • Sequenom, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Technology
  • Market Snippet, By Application
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis

4. Global SNP Genotyping and Analysis Market, By Technology, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • SNP Microarray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Taqman Allelic Discrimination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • SNP Pyrosequencing Technologies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • ABISNPlex
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Sequenom Mass-Array MALDI-TOF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
    • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends

5. Global SNP Genotyping and Analysis Market, By Application, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Pharmaceuticals and Pharmacogenomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Diagnostic Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Agricultural Biotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Breeding and Animal Livestock
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global SNP Genotyping and Analysis Market, By Regions, 2017 - 2028 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

    • Company Profiles
  • LGC Limited
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fluidigm Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Life Technologies Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PREMIER Biosoft
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sequenom, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

    • References
    • Research Methodology
    • About us and Sales Contact